Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 8,281–8,340 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

University of Milano-Bicocca1 University of Minnesota Advanced Research Diagnostic Laboratory1 University of Montreal1 University of Muenster1 University of Nebraska Medical Centre1 University of New Brunswick1 University of Newcastle HREC1 University of Newcastle upon Tyne1 University of Nigeria Teaching Hospital1 University of North Carolina IUCAC1 University of North Carolina Thurston Arthritis Research Center1 University of North Carolina at Chapel Hill Institutional Review Board1 University of Notre Dame Australia1 University of Oklahoma1 University of Oklahoma Health Sciences Center1 University of Oldenburg1 University of Osaka Hospital1 University of Oslo1 University of Ottawa Heart Institute1 University of Ottawa Research Ethics Board1 University of Padua1 University of Perugia1 University of Pittsburgh Medical Center1 University of Pittsburgh School of Medicine1 University of Pécs1 University of Rwanda1 University of San Carlos–Extension1 University of Santo Amaro1 University of Saskatchewan1 University of Social Welfare and Rehabilitation Sciences1 University of Sorocaba1 University of South Australia1 University of South Australia HREC1 University of South China1 University of Southern California Keck School of Medicine1 University of Stirling1 University of São Paulo1 University of Texas MD Anderson Cancer Center1 University of Texas Physicians1 University of Texas at Austin1 University of Texas – Houston1 University of Tokyo1 University of Toronto Lupus Clinic1 University of Tsukuba Hospital1 University of Turin1 University of Ulm1 University of Utah Heritage 1000 Projects1 University of Vermont1 University of Vermont Institutional Review Board1 University of Verona1 University of Victoria1 University of Virginia Flow Cytometry Core1 University of Warwick1 University of Winchester1 University of Wisconsin Carbone Cancer Center1 University of Wisconsin Carbone Cancer Centre1 University of Wisconsin Institutional Animal Care and Use Committee1 University of Wisconsin Institutional Review Board1 University of Wolverhampton1 University of Würzburg1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 170 of 946

776 Melanoma tumor cells and immunotherapy cooperatively reprogram bone marrow niches to induce early hematopoietic dysfunction and therapy-related myeloid neoplasms

jitc · abstract · 2025-11-04 · 3 matching annotations

81.4%

Embase PubMed Scopus Melanoma immune checkpoint inhibitors immune checkpoint inhibitor therapy myelodysplastic syndromes therapy-related myeloid neoplasms

…nsive literature review was conducted using PubMed, Scopus, and Embase. Studies included mechanistic models, clinical reports, and coh…

777 Natural killer cells are prognostic for head and neck squamous cell carcinoma patients treated with radiation therapy, which induces cancer cell immunogenicity in preclinical models

jitc · abstract · 2025-11-04 · 3 matching annotations

80.3%

TCGA The Cancer Genome Atlas advanced head and neck squamous cell carcinoma (HNSCC)Radiation therapy ICIs

…ic healthy mouse splenocytes followed by flow cytometry.Results TCGA analysis revealed that pre-treatment expression of a signature …

810 Chemerin-CMKLR1 axis modulates NK cell functional responses in prostate cancer

jitc · abstract · 2025-11-04 · 3 matching annotations

89.2%

Washington University School of Medicine Alvin J. Siteman Cancer Center Siteman Cancer Center rhChemerin Chemerin prostate cancer PCa α-NETA rhChemerin-treated

…s for our study. We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine, Barnes-Jewish Hospital in St. Louis, MO., for the use of the I…

852 AZD6750: design and efficacy of a CD8-guided IL-2 that enhances CD8+ T cell function

jitc · abstract · 2025-11-04 · 3 matching annotations

83.9%

NSG mice East of England - Cambridge East Research Ethics Committee UKCCR Aldesleukin AZD6750 IL-2

…ZD6750, and the activity evaluated by IFN-γ secretion. In vivo, NSG mice were implanted subcutaneously with pp65 antigen-expressing tumo…

858 Tumour-localising IL-15 superagonist for intravenous delivery enhances survival and reduces toxicity in solid tumour models

jitc · abstract · 2025-11-04 · 3 matching annotations

93.9%

Imperial College London Cancer Research UK’s Convergence Science Centre IL-15SA pancreatic adenocarcinoma CT26 PBS CT26 tumours KPC

…-approved project license and overseen by ethical committees of Imperial College London.Abstract 858 Figure 1CBD IL-15SA improves survival in CT26 and …

861 Sequential administration of WTX-124 and mWTX-330, IL-2 and IL-12 INDUKINE™ molecules, enhanced antitumor activity in mice bearing poorly immunogenic EMT6 tumors without systemic toxicity

jitc · abstract · 2025-11-04 · 3 matching annotations

87.5%

Charles River Laboratories U.S. Department of Agriculture NIH WTX-330 WTX-124 mWTX-330

… standards of the U.S. Department of Agriculture and the NIH at Charles River Laboratories with the approval of an Institutional Animal Care and Use Commi…

862 Pharmacokinetic insight into the IL-2 INDUKINE prodrug WTX-124: Real-time assessment of tumor-specific activation and immune modulation

jitc · abstract · 2025-11-04 · 3 matching annotations

84.0%

Charles River Laboratories Den Bosch B.V.Charles River Laboratories U.S Department of Health and Human Services WTX-124 INDUKINE Public Health Service

…ory Animal Welfare (OLAW). All animal studies were conducted at Charles River Laboratories Den Bosch B.V. (location Groningen, the Netherlands) with approval of the Char…

890 Intravesical recombinant MVA therapy induces local and systemic antitumor immunity and memory in an orthotopic murine bladder cancer model

jitc · abstract · 2025-11-04 · 3 matching annotations

97.7%

Memorial Sloan Kettering Cancer Center Rockefeller University MQ833 Center for Experimental Therapeutics Grant MQ710 Non-muscle-invasive bladder cancer (NMIBC)NMIBC

…10 is currently in a Phase I clinical trial for solid tumors at Memorial Sloan Kettering Cancer Center. Here, we assessed intravesical delivery of second-generation r…

895 The lack of abscopal effects with oncolytic virus immunotherapy is due to a dominant anti-viral – rather than anti-cancer – T cell response

jitc · abstract · 2025-11-04 · 3 matching annotations

87.2%

Massachusetts General Hospital MGH MGH Pathology Flow Core melanoma Talimogene laherparepvec talimogene laherparapvec pembrolizumab

…25;32(1):482–494.Ethics Approval This study was approved by the Massachusetts General Hospital (MGH) Institutional Animal Care and Use Committee; protocol num…

896 Oncolytic vaccinia virus-mediated immunotherapy increases survival and reduces tumour growth by turning immunologically ‘cold’ oestrogen receptor-positive breast tumours ‘hot’

jitc · abstract · 2025-11-04 · 3 matching annotations

87.8%

QMUL ICR Flow Cytometry Facility Breast Cancer Now Histopathology Core Facility VacV000 Pembrolizumab Oestrogen receptor-positive (ER+) breast cancer (BC)chemotherapy-ICI combinations breast cancer nivolumab

…n oncolytic Lister strain Vaccinia virus (VacV000; developed at QMUL and VacVBTX) in preclinical models of ER+ BC.Methods Human and …

936 Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy

jitc · abstract · 2025-11-04 · 3 matching annotations

93.7%

Columbia University Irving Medical Center Jackson Laboratory Mendelsohn lab cancer cancerAbstract NIH/NCI R01CA249160 Charles H. Revson Foundation NIH/NCI R01CA259634 PD-1 blockade NIH/NCI U01CA247573+1 more

…g Comprehensive Cancer Center, and the Histology Service at the Columbia University Irving Medical Center. This work was supported by NIH/NCI R01CA249160, NIH/NCI R01CA2…

99 Research use only validation of ‘Off the Shelf’ multiPlex immunofluorescence panels with quantitative image analysis for use in retrospective clinical trials

jitc · abstract · 2025-11-04 · 3 matching annotations

80.1%

EC Institutional Review Board immunotherapy tyramide

…andard if outside the United States. Waiver of Consent: The IRB/EC has approved the use of Biospecimens and/or data without writte…